digital health companies glp-1 management Virtual startups: Pill mills or the future of obesity care? The future of GLP-1 drugs
Description
With Semaglutide patents expiring in 2026, Indian pharma has a chance to lead the GLP-1 drug market.
We'll look at the requirements, how to check your own benefits, and what steps you can take to get approved
TRT and GLP-1 are the two drugs that would get an athlete banned
By the end of 2024, GLP-1 volume had surpassed 9M prescriptions
This week, we analysed over 70,000 activities from 305 users taking GLP-1 medication
STEP 4
